Correction to: One shot NEPA plus dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in sarcoma patients receiving multiple-day chemotherapy (Supportive Care in Cancer, (2019), 27, 9, (3593-3597), 10.1007/s00520-019-4645-3)

Correction to: The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of neoadjuvant chemotherapy (Virchows Archiv, (2020), 477, 4, (535-544), 10.1007/s00428-020-02795-8)

van Baal, J. O.A.M.
Lok, C. A.R.
Jordanova, E. S.
Horlings, H.
van Driel, W. J.
Amant, F. C.
Van de Vijver, K. K.

January 2020

A correction to this paper has been published: https://doi.org/10.1007/s00428-020-02974-7

Correction to : Determination of the absolute oral bioavailability of niraparib by simultaneous administration of aC-microtracer and therapeutic dose in cancer patients

van Andel, L
Rosing, H.
Zhang, Z
Hughes, L.
Kansra, V
Sanghvi, M
Tibben, M.
Gebretensae, A.
Schellens, J H M
Beijnen, J H

January 2018

The article ''Determination of the absolute oral bioavailability of niraparib by simultaneous admini...

Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial.

Kolias, AG
Edlmann, E
Thelin, EP
Bulters, D
Holton, P
Suttner, N
Owusu-Agyemang, K
Al-Tamimi, YZ
Gatt, D
Thomson, S
Anderson, IA
Richards, O
Whitfield, P
Gherle, M
Caldwell, K
Davis-Wilkie, C
Tarantino, S
Barton, G
Marcus, HJ
Chari, A
Brennan, P
Belli, A
Bond, S
Turner, C
Whitehead, L
Wilkinson, I
Hutchinson, PJ
British Neurosurgical Trainee Research Collaborative (BNTRC) and Dex-CSDH Trial Collaborators

March 2019

After publication of the original article [1], the authors notified that that one of the BNTRC insti...

Successful strategies in implementing a multidisciplinary team working in the care of patients with cancer: an overview and synthesis of the available literature [Corrigendum]

Soukup T
Lamb BW
Arora S
Darzi A
Sevdalis N
Green JSA

June 2018

Soukup T, Lamb BW, Arora S, Darzi A, Sevdalis N, Green JSA. J Multidisip Healthc. 2018;11:49–6...

Correction to: ASO Author Reflections: Addition of Induction Chemotherapy Prior to Neoadjuvant Chemo(Re)Irradiation in Patients with Locally Recurrent Rectal Cancer to Improve Long-Term Outcomes

Voogt, E.L.K.
Burger, J.W.A.
Rutten, H.J.T.

December 2020

In the original article Jacobus W. A. Burger's first name is incorrect. It is correct as reflected h...

Correction: Xiao, X., et al. Synthesis, Cytotoxicity and Apoptosis Induction in Human Tumor Cells by Galaxamide and Its Analogues. Mar. Drugs 2014, 12, 4521–4538

Xi Xiao

September 2014

We have found the following error in the title of this article, which was recently published in Mar...

Correction to: Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.

De Bari, B.
Franzetti-Pellanda, A.
Saidi, A.
Biggiogero, M.
Hahnloser, D.
Montemurro, M.
Bourhis, J.
Zeverino, M.
Ozsahin, M.

August 2019

The article "Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guid...

Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.

Sutherland, K.A.
Parry, C.M.
McCormick, A.L.
Kapaata, A.
Lyagoba, F.
Kaleebu, P.
Gilks, C.F.
Goodall, R.
Spyer, M.
Kityo, C.
Pillay, D.
Gupta, R.K.
DART Virology Group
Sutherland, K.A.
Parry, C.M.
McCormick, A.L.
Kapaata, A.
Lyagoba, F.
Kaleebu, P.
Gilks, C.F.
Goodall, R.
Spyer, M.
Kityo, C.
Pillay, D.
Gupta, R.K.
DART Virology Group

January 2016

The title of this article should include “HIV-1.” The correct title is: Evidence for Reduced HIV-1 D...

Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]

Manu, K.
Shanmugam, M.
Ramachandran, L.
Li, F.
Siveen, K.
Chinnathambi, A.
Zayed, M.
Alharbi, S.
Arfuso, Frank
Kumar, Alan Prem
Ahn, K.
Sethi, G.

January 2018

Correction to: Olaratumab in combination with doxorubicin for the treatment of advanced soft tissue sarcoma: an evidence review group perspective of a National Institute for Health and Care Excellence single technology appraisal

Tikhonova, Irina A.
Jones-Hughes, Tracey
Dunham, James
Warren, Fiona C.
Robinson, Sophie
Stephens, Peter
Hoyle, Martin

April 2018

Correction to: PharmacoEconomics (2018) 36:39-49 https://doi.org/10.1007/s40273-017-0568

Correction to: Prevention of seroma following inguinal lymph node dissection with prophylactic, incisional, negative-pressure wound therapy (SEROMA trial): study protocol for a randomized controlled trial

Mads Gustaf Jørgensen
Navid Mohamadpour Toyserkani
Nana Hyldig
Annette Hougaard Chakera
Lisbet Rosenkrantz Hölmich
Jørn Bo Thomsen
Jens Ahm Sørensen

October 2018

Following publication of the original article [1], the authors reported that one of the authors’ nam...

Correction to: Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach (Neurological Sciences, (2017), 38, 10, (1849-1858), 10.1007/s10072-017-3081-8)

Amato, Maria Pia
Bertolotto, Antonio
Brunelli, Roberto
Cavalla, Paola
Goretti, Benedetta
Marrosu, Maria Giovanna
Patti, Francesco
Pozzilli, Carlo
Provinciali, Leandro
Rizzo, Nicola
Strobelt, Nicola
Tedeschi, Gioacchino
Trojano, Maria
Comi, Giancarlo

January 2018

The original version contained a mistake. The authors have specified only in a few paragraphs that a...

Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

Alsina, Maria
Rivera, Fernando
Ramos, Francisco Javier
Galán, Maica
López, Rafael
García-Alfonso, Pilar
Alés-Martinez, José Enrique
Queralt, Bernardo
Antón, Antonio
Carrato, Alfredo
Grávalos, Cristina
Méndez-Vidal, Maria José
López, Carlos
de Mena, Inmaculada Ruiz
Tabernero, Josep
Giralt, Jordi
Aranda, Enrique
Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR)

January 2018

Errors were subsequently identified in the article and the following corrections should be noted

Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

Martínez-Cuadrón, David
Boluda, Blanca
Martínez, Pilar
Bergua, Juan
Rodríguez-Veiga, Rebeca
Esteve, Jordi
Vives, Susana
Serrano, Josefina
Vidriales, Belen
Salamero, Olga
Cordón, Lourdes
Sempere, Amparo
Jiménez-Ubieto, Ana
Prieto-Delgado, Julio
Díaz-Beyá, Marina
Garrido, Ana
Benavente, Celina
Pérez-Simón, José Antonio
Moscardó, Federico
Sanz, Miguel A
Montesinos, Pau
CETLAM and PETHEMA groups

January 2018

The name of Pau Montesinos was inadvertently presented as Pau Montesinos Fernández in the original a...

Correction to: Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization

Verheijen, R B
Swart, E L
Beijnen, J H
Schellens, J H M
Huitema, A D R
Steeghs, N

July 2020

Correction to: Cancer Chemother Pharmacol (2017) 80:1171–1178 https://doi-org.proxy.library.uu.nl/10...

Correction to: The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of neoadjuvant chemotherapy (Virchows Archiv, (2020), 477, 4, (535-544), 10.1007/s00428-020-02795-8)

van Baal, J. O.A.M.
Lok, C. A.R.
Jordanova, E. S.
Horlings, H.
van Driel, W. J.
Amant, F. C.
Van de Vijver, K. K.

January 2020

A correction to this paper has been published: https://doi.org/10.1007/s00428-020-02974-7

Correction to : Determination of the absolute oral bioavailability of niraparib by simultaneous administration of aC-microtracer and therapeutic dose in cancer patients

van Andel, L
Rosing, H.
Zhang, Z
Hughes, L.
Kansra, V
Sanghvi, M
Tibben, M.
Gebretensae, A.
Schellens, J H M
Beijnen, J H

January 2018

The article ''Determination of the absolute oral bioavailability of niraparib by simultaneous admini...

Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial.

Kolias, AG
Edlmann, E
Thelin, EP
Bulters, D
Holton, P
Suttner, N
Owusu-Agyemang, K
Al-Tamimi, YZ
Gatt, D
Thomson, S
Anderson, IA
Richards, O
Whitfield, P
Gherle, M
Caldwell, K
Davis-Wilkie, C
Tarantino, S
Barton, G
Marcus, HJ
Chari, A
Brennan, P
Belli, A
Bond, S
Turner, C
Whitehead, L
Wilkinson, I
Hutchinson, PJ
British Neurosurgical Trainee Research Collaborative (BNTRC) and Dex-CSDH Trial Collaborators

March 2019

After publication of the original article [1], the authors notified that that one of the BNTRC insti...

Successful strategies in implementing a multidisciplinary team working in the care of patients with cancer: an overview and synthesis of the available literature [Corrigendum]

Soukup T
Lamb BW
Arora S
Darzi A
Sevdalis N
Green JSA

June 2018

Soukup T, Lamb BW, Arora S, Darzi A, Sevdalis N, Green JSA. J Multidisip Healthc. 2018;11:49–6...

Correction to: ASO Author Reflections: Addition of Induction Chemotherapy Prior to Neoadjuvant Chemo(Re)Irradiation in Patients with Locally Recurrent Rectal Cancer to Improve Long-Term Outcomes

Voogt, E.L.K.
Burger, J.W.A.
Rutten, H.J.T.

December 2020

In the original article Jacobus W. A. Burger's first name is incorrect. It is correct as reflected h...

Correction: Xiao, X., et al. Synthesis, Cytotoxicity and Apoptosis Induction in Human Tumor Cells by Galaxamide and Its Analogues. Mar. Drugs 2014, 12, 4521–4538

Xi Xiao

September 2014

We have found the following error in the title of this article, which was recently published in Mar...

Correction to: Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series.

De Bari, B.
Franzetti-Pellanda, A.
Saidi, A.
Biggiogero, M.
Hahnloser, D.
Montemurro, M.
Bourhis, J.
Zeverino, M.
Ozsahin, M.

August 2019

The article "Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guid...

Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.

Sutherland, K.A.
Parry, C.M.
McCormick, A.L.
Kapaata, A.
Lyagoba, F.
Kaleebu, P.
Gilks, C.F.
Goodall, R.
Spyer, M.
Kityo, C.
Pillay, D.
Gupta, R.K.
DART Virology Group
Sutherland, K.A.
Parry, C.M.
McCormick, A.L.
Kapaata, A.
Lyagoba, F.
Kaleebu, P.
Gilks, C.F.
Goodall, R.
Spyer, M.
Kityo, C.
Pillay, D.
Gupta, R.K.
DART Virology Group

January 2016

The title of this article should include “HIV-1.” The correct title is: Evidence for Reduced HIV-1 D...

Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]

Manu, K.
Shanmugam, M.
Ramachandran, L.
Li, F.
Siveen, K.
Chinnathambi, A.
Zayed, M.
Alharbi, S.
Arfuso, Frank
Kumar, Alan Prem
Ahn, K.
Sethi, G.

January 2018

Correction to: Olaratumab in combination with doxorubicin for the treatment of advanced soft tissue sarcoma: an evidence review group perspective of a National Institute for Health and Care Excellence single technology appraisal

Tikhonova, Irina A.
Jones-Hughes, Tracey
Dunham, James
Warren, Fiona C.
Robinson, Sophie
Stephens, Peter
Hoyle, Martin

April 2018

Correction to: PharmacoEconomics (2018) 36:39-49 https://doi.org/10.1007/s40273-017-0568

Correction to: Prevention of seroma following inguinal lymph node dissection with prophylactic, incisional, negative-pressure wound therapy (SEROMA trial): study protocol for a randomized controlled trial

Mads Gustaf Jørgensen
Navid Mohamadpour Toyserkani
Nana Hyldig
Annette Hougaard Chakera
Lisbet Rosenkrantz Hölmich
Jørn Bo Thomsen
Jens Ahm Sørensen

October 2018

Following publication of the original article [1], the authors reported that one of the authors’ nam...

Correction to: Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach (Neurological Sciences, (2017), 38, 10, (1849-1858), 10.1007/s10072-017-3081-8)

Amato, Maria Pia
Bertolotto, Antonio
Brunelli, Roberto
Cavalla, Paola
Goretti, Benedetta
Marrosu, Maria Giovanna
Patti, Francesco
Pozzilli, Carlo
Provinciali, Leandro
Rizzo, Nicola
Strobelt, Nicola
Tedeschi, Gioacchino
Trojano, Maria
Comi, Giancarlo

January 2018

The original version contained a mistake. The authors have specified only in a few paragraphs that a...

Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.

Alsina, Maria
Rivera, Fernando
Ramos, Francisco Javier
Galán, Maica
López, Rafael
García-Alfonso, Pilar
Alés-Martinez, José Enrique
Queralt, Bernardo
Antón, Antonio
Carrato, Alfredo
Grávalos, Cristina
Méndez-Vidal, Maria José
López, Carlos
de Mena, Inmaculada Ruiz
Tabernero, Josep
Giralt, Jordi
Aranda, Enrique
Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and Grupo de Investigación Clínica en Oncología Radioterápica (GICOR)

January 2018

Errors were subsequently identified in the article and the following corrections should be noted

Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.

Martínez-Cuadrón, David
Boluda, Blanca
Martínez, Pilar
Bergua, Juan
Rodríguez-Veiga, Rebeca
Esteve, Jordi
Vives, Susana
Serrano, Josefina
Vidriales, Belen
Salamero, Olga
Cordón, Lourdes
Sempere, Amparo
Jiménez-Ubieto, Ana
Prieto-Delgado, Julio
Díaz-Beyá, Marina
Garrido, Ana
Benavente, Celina
Pérez-Simón, José Antonio
Moscardó, Federico
Sanz, Miguel A
Montesinos, Pau
CETLAM and PETHEMA groups

January 2018

The name of Pau Montesinos was inadvertently presented as Pau Montesinos Fernández in the original a...

Correction to: Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization

Verheijen, R B
Swart, E L
Beijnen, J H
Schellens, J H M
Huitema, A D R
Steeghs, N

July 2020

Correction to: Cancer Chemother Pharmacol (2017) 80:1171–1178 https://doi-org.proxy.library.uu.nl/10...

Correction to: The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of neoadjuvant chemotherapy (Virchows Archiv, (2020), 477, 4, (535-544), 10.1007/s00428-020-02795-8)

van Baal, J. O.A.M.
Lok, C. A.R.
Jordanova, E. S.
Horlings, H.
van Driel, W. J.
Amant, F. C.
Van de Vijver, K. K.

January 2020

A correction to this paper has been published: https://doi.org/10.1007/s00428-020-02974-7

Correction to : Determination of the absolute oral bioavailability of niraparib by simultaneous administration of aC-microtracer and therapeutic dose in cancer patients

van Andel, L
Rosing, H.
Zhang, Z
Hughes, L.
Kansra, V
Sanghvi, M
Tibben, M.
Gebretensae, A.
Schellens, J H M
Beijnen, J H

January 2018

The article ''Determination of the absolute oral bioavailability of niraparib by simultaneous admini...

Correction to: Dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) trial: study protocol for a randomised controlled trial.

Kolias, AG
Edlmann, E
Thelin, EP
Bulters, D
Holton, P
Suttner, N
Owusu-Agyemang, K
Al-Tamimi, YZ
Gatt, D
Thomson, S
Anderson, IA
Richards, O
Whitfield, P
Gherle, M
Caldwell, K
Davis-Wilkie, C
Tarantino, S
Barton, G
Marcus, HJ
Chari, A
Brennan, P
Belli, A
Bond, S
Turner, C
Whitehead, L
Wilkinson, I
Hutchinson, PJ
British Neurosurgical Trainee Research Collaborative (BNTRC) and Dex-CSDH Trial Collaborators

March 2019

After publication of the original article [1], the authors notified that that one of the BNTRC insti...

Correction to: One shot NEPA plus dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in sarcoma patients receiving multiple-day chemotherapy (Supportive Care in Cancer, (2019), 27, 9, (3593-3597), 10.1007/s00520-019-4645-3)

Abstract

Extracted data

Correction to: One shot NEPA plus dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in sarcoma patients receiving multiple-day chemotherapy (Supportive Care in Cancer, (2019), 27, 9, (3593-3597), 10.1007/s00520-019-4645-3)

Abstract

Extracted data

Related items

Related items